Case Report of Drug-Induced Hepatitis with Anti-SLA Antibodies
Author Information
Author(s): Etxagibel Aitziber, Julià M Rosa, Brotons Alvaro, Company M Margarita, Dolz Carlos
Primary Institution: Department of Family Practice Post-graduate Unit, Palma de Mallorca, Spain
Hypothesis
Could the presence of anti-soluble liver antigens precede the development of autoimmune hepatitis?
Conclusion
The patient likely experienced drug-induced hepatitis alongside an unknown autoimmune hepatitis.
Supporting Evidence
- The patient developed liver dysfunction after taking medication.
- Biochemical parameters normalized after drug withdrawal.
- Anti-SLA autoantibodies remained positive even after symptoms resolved.
Takeaway
A 66-year-old woman had liver problems after taking medication, and even after stopping the drugs, some signs of liver issues remained.
Methodology
The case involved clinical evaluation, serological tests, and liver biopsies to assess liver function and autoimmune markers.
Limitations
The study is based on a single case, limiting generalizability.
Participant Demographics
66-year-old Caucasian woman with a history of diabetes and osteoporosis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website